The first clinical guidance for cardiogenic shock will be presented at the American College of Cardiology Scientific Session ...

Supira Medical, Inc., today announced the successful completion of an oversubscribed Series E financing round, raising $120M ...

Supira Medical announced today that it completed an oversubscribed Series E financing round, bringing in $120 million.

Supira Medical, Inc. (Supira), a clinical-stage Shifamed portfolio company, today announced the successful completion of an ...

Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating biotech and advancing early and late-stage innovative ...

The US data also point to lower costs and shorter stays at these expert centers, an argument for regionalized care akin to ...

Cardiogenic shock remains a challenging clinical syndrome characterized by critically impaired cardiac output, systemic hypoperfusion, and high mortality ...

In this “data-scarce zone,” the paper offers a road map for the first 24 hours and tips for transfer, teams, and more.

The following is a summary of “ICU mortality of post-myocardial infarction ventricular septal defect complicated by ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

Should heart failure with supranormal ejection fraction (EF) be considered separate from preserved ejection fraction?